Position in VRTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$992,963
+$99,437 QoQ
Shares Held
1,999
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#854
of 1,735 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Advisory Alpha, LLC holds $2,276,517 across 6 Biotechnology names. VRTX ranks #1 (43.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,999 | $992,963 | |
| 2 | TECH |
BIO-TECHNE Corp
|
7,581 | $535,597 | |
| 3 | INCY |
Incyte Corp
|
3,844 | $435,755 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
4,378 | $250,509 | |
| 5 | AVXL |
Anavex Life Sciences Corp.
|
18,839 | $48,793 | |
| 6 | DRMA |
Dermata Therapeutics, Inc.
|
10,000 | $12,900 |
All Filings in VRTX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $992,963 | 1,999 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $893,526 | 2,001 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $913,067 | 2,014 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $725,317 | 1,852 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $757,285 | 1,701 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $734,017 | 1,514 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $520,288 | 1,292 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $546,469 | 1,175 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $462,626 | 987 | Shares | Sole | 2024-08-21 | |
| 2024-03-31 | $355,726 | 851 | Shares | Sole | 2024-05-06 | |
| 2020-09-30 | $18,232 | 67 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $40,451 | 170 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||